The use of bone cement for the localized, controlled release of the antibiotics vancomycin, linezolid, or fusidic acid: Effect of additives on drug release rates and mechanical strength

Drug Delivery and Translational Research

Volumn 1, Issue 2, 2011, Pages 121-131

  Jackson, John ^a   Leung, Fay ^b   Duncan, Clive ^b   Mugabe, Clement ^a   Burt, Helen ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

Antibiotics; Bone cement; Controlled release; MRSA

Indexed keywords

DEXTRAN; DRUG ADDITIVE; FUSIDIC ACID; LINEZOLID; MACROGOL; PALACOS; PHOSPHATE BUFFERED SALINE; POLY(METHYL METHACRYLATE); SODIUM CHLORIDE; VANCOMYCIN;

ARTICLE; COMPOSITE MATERIAL; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; STRENGTH; THERMAL ANALYSIS; YOUNG MODULUS;

EID: 84863010155     PISSN: 2190393X     EISSN: 21903948     Source Type: Journal    
DOI: 10.1007/s13346-011-0015-5     Document Type: Article

References (43)

1. Aboltins CA, Page MA, Buising KL, Jenney AW, Daffy JR, Choong PF, et al. Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid. Clin Microbiol Infect. 2007; 13: 586-91.
2. Anagnostakos K, Kelm J, Grun S, Schmitt E, Jung W, Swoboda S. Antimicrobial properties and elution kinetics of linezolid-loaded hip spacers in vitro. J Biomed Mater Res B Appl Biomater. 2008; 87: 173-8.
3. Anagnostakos K, Wilmes P, Schmitt E, Kelm J. Elution of gentamicin and vancomycin from polymethylmethacrylate beads and hip spacers in vivo. Acta Orthop. 2009; 80: 193-7.
4. Andollina A, Bertoni G, Zolezzi C, Trentani F, Trentani P, Maria Borrelli A, et al. Vancomycin and meropenem in acrylic cement: elution kinetics of in vitro bactericidal action. Chir Organi Mov. 2008; 91: 153-8.
5. Anguita-Alonso P, Rouse MS, Piper KE, Jacofsky DJ, Osmon DR, Patel R. Comparative study of antimicrobial release kinetics from polymethylmethacrylate. Clin Orthop Relat Res. 2006; 445: 239-44.
6. Atkins B, Gottlieb T. Fusidic acid in bone and joint infections. Int J Antimicrob Agents. 1999; 12 Suppl 2: S79-93.
7. Baleani M, Persson C, Zolezzi C, Andollina A, Borrelli AM, Tigani D. Biological and biomechanical effects of vancomycin and meropenem in acrylic bone cement. J Arthroplasty. 2008; 23: 1232-8.
8. Benoit MA, Mousset B, Delloye C, Bouillet R, Gillard J. Antibiotic-loaded plaster of Paris implants coated with poly lactide-co-glycolide as a controlled release delivery system for the treatment of bone infections. Int Orthop. 1997; 21: 403-8.
9. Coban AY, Bilgin K, Uzun M, Durupinar B. Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates. Mikrobiyol Bül. 2009; 43: 293-7.
10. Darouiche RO, Landon GC, Patti JM, Nguyen LL, Fernau RC, McDevitt D, et al. Role of Staphylococcus aureus surface adhesins in orthopaedic device infections: are results model-dependent? J Med Microbiol. 1997; 46: 75-9.
11. De Cock E, Krueger WA, Sorensen S, Baker T, Hardewig J, Duttagupta S, et al. Cost-effectiveness of linezolid vs vancomycin in suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany. Infection. 2009; 37: 123-32.
12. Drognitz O, Thorn D, Kruger T, Gatermann SG, Iven H, Bruch HP, et al. Release of vancomycin and teicoplanin from a plasticized and resorbable gelatin sponge: in vitro investigation of a new antibiotic delivery system with glycopeptides. Infection. 2006; 34: 29-34.
13. Elson RA, Jephcott AE, McGechie DB, Verettas D. Antibiotic-loaded acrylic cement. J Bone Joint Surg. 1977; 59-B: 200-5.
14. Ersoz G, Oztuna V, Coskun B, Eskandari MM, Bayarslan C, Kaya A. Addition of fusidic acid impregnated bone cement to systemic teicoplanin therapy in the treatment of rat osteomyelitis. J Chemother. 2004; 16: 51-5.
15. Falagas ME, Vardakas KZ. Benefit-risk assessment of linezolid for serious Gram-positive bacterial infections. Drug Saf. 2008; 31: 753-68.
16. Fluckiger U, Ulrich M, Steinhuber A, Doring G, Mack D, Landmann R, et al. Biofilm formation, icaADBC transcription, and polysaccharide intercellular adhesin synthesis by Staphylococci in a device-related infection model. Infect Immun. 2005; 73: 1811-9.
17. Hsieh PH, Huang KC, Tai CL. Liquid gentamicin in bone cement spacers: in vivo antibiotic release and systemic safety in two-stage revision of infected hip arthroplasty. J Trauma. 2009; 66: 804-8.
18. Jackson JK, Min W, Cruz TF, Cindric S, Arsenault L, Von Hoff DD, et al. A polymer-based drug delivery system for the antineoplastic agent bis(maltolato)oxovanadium in mice. Br J Cancer. 1997; 75: 1014-20.
19. Jang HC, Kim SH, Kim KH, Kim CJ, Lee S, Song KH, et al. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem. Clin Infect Dis. 2009; 49: 395-401.
20. Joosten U, Joist A, Gosheger G, Liljenqvist U, Brandt B, von Eiff C. Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis. Biomaterials. 2005; 26: 5251-8.
21. Kanellakopoulou K, Giamarellos-Bourboulis EJ. Carrier systems for the local delivery of antibiotics in bone infections. Drugs. 2000; 59: 1223-32.
22. Kohno S, Yamaguchi K, Aikawa N, Sumiyama Y, Odagiri S, Aoki N, et al. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan. J Antimicrob Chemother. 2007; 60: 1361-9.
23. Kuechle DK, Landon GC, Musher DM, Noble PC. Elution of vancomycin, daptomycin, and amikacin from acrylic bone cement. Clin Orthop Relat Res. 1991; 264: 302-8.
24. Lilikakis A, Sutcliffe MP. The effect of vancomycin addition to the compression strength of antibiotic-loaded bone cements. Int Orthop. 2009; 33: 815-9.
25. Maviglia R, Nestorini R, Pennisi M. Role of old antibiotics in multidrug resistant bacterial infections. Curr Drug Targets. 2009; 10: 895-905.
26. Neut D, Hendriks JG, van Horn JR, Kowalski RS, van der Mei HC, Busscher HJ. Antimicrobial efficacy of gentamicin-loaded acrylic bone cements with fusidic acid or clindamycin added. J Orthop Res. 2006; 24: 291-9.
27. Nguyen S, Pasquet A, Legout L, Beltrand E, Dubreuil L, Migaud H, et al. Efficacy and tolerance of rifampicin-linezolid compared with rifampicin-cotrimoxazole combinations in prolonged oral therapy for bone and joint infections. Clin Microbiol Infect. 2009; 15(12): 1163-9.
28. Perry CM, Jarvis B. Linezolid: a review of its use in the management of serious Gram-positive infections. Drugs. 2001; 61: 525-51.
29. Persson C, Baleani M, Guandalini L, Tigani D, Viceconti M. Mechanical effects of the use of vancomycin and meropenem in acrylic bone cement. Acta Orthop. 2006; 77: 617-21.
30. Rao N, Hamilton CW. Efficacy and safety of linezolid for Gram-positive orthopedic infections: a prospective case series. Diagn Microbiol Infect Dis. 2007; 59: 173-9.
31. Scott CP, Higham PA, Dumbleton JH. Effectiveness of bone cement containing tobramycin. An in vitro susceptibility study of 99 organisms found in infected joint arthroplasty. J Bone Joint Surg Br. 1999; 81: 440-3.
32. Singh SR, Bacon 3rd AE, Young DC, Couch KA. In vitro 24-hour time-kill studies of vancomycin and linezolid in combination versus methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2009; 53: 4495-7.
33. Stevens DL, Herr D, Lampiris H, Hunt JL, Batts DH, Hafkin B. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis. 2002; 34: 1481-90.
34. Stryjewski ME, Corey GR. New treatments for methicillin-resistant Staphylococcus aureus. Curr Opin Crit Care. 2009; 15: 403-12.
35. Trampuz A, Widmer AF. Infections associated with orthopedic implants. Curr Opin Infect Dis. 2006; 19: 349-56.
36. Trampuz A, Zimmerli W. Antimicrobial agents in orthopaedic surgery: prophylaxis and treatment. Drugs. 2006; 66: 1089-105.
37. Ueng SW, Yuan LJ, Lee N, Lin SS, Chan EC, Weng JH. In vivo study of biodegradable alginate antibiotic beads in rabbits. J Orthop Res. 2004; 22: 592-9.
38. Vercillo M, Patzakis MJ, Holtom P, Zalavras CG. Linezolid in the treatment of implant-related chronic osteomyelitis. Clin Orthop Relat Res. 2007; 461: 40-3.
39. Veyries ML, Couarraze G, Geiger S, Agnely F, Massias L, Kunzli B, et al. Controlled release of vancomycin from poloxamer 407 gels. Int J Pharm. 1999; 192: 183-93.
40. Vinh DC, Rubinstein E. Linezolid: a review of safety and tolerability. J Infect. 2009; 59 Suppl 1: S59-74.
41. Winternitz CI, Jackson JK, Oktaba AM, Burt HM. Development of a polymeric surgical paste formulation for taxol. Pharm Res. 1996; 13: 368-75.
42. Yan S, Cai X, Yan W, Dai X, Wu H. Continuous wave ultrasound enhances vancomycin release and antimicrobial efficacy of antibiotic-loaded acrylic bone cement in vitro and in vivo. J Biomed Mater Res B Appl Biomater. 2007; 82: 57-64.
43. Zalavras CG, Patzakis MJ, Holtom P. Local antibiotic therapy in the treatment of open fractures and osteomyelitis. Clin Orthop Relat Res. 2004; 427: 86-93.